pharma · Chronic Lymphocytic Leukemia (CLL) · Relapsed/Refractory B-cell Malignancies · NRIX
Nurix Therapeutics
News and analysis for Nurix Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.
Brisbane, USA HQ
2012 Founded
350 Employees
Public company Type
NRIX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Brisbane, USA
- Founded
- 2012
- Employees
- 350
- Programs
- 9
- Drugs
- 4
- Patents
- 14
News & analysis
NovaPharmaNews articles mentioning Nurix Therapeutics — regulatory, clinical, and market coverage.
News and analysis for Nurix Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.